Methoxy PEG dithiol NHS - MW 1000 Da

Cat. No.: M163950
Disponibile su ordine
QUALITÀ & PUREZZA MW 1000 Da
Storage
Protected from light,Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
100mg
M163950-100mg
—
1 Disponibile

102,31€

119,66€
Salva 17,35 € (14.50%)
500mg
M163950-500mg
—
1 Disponibile

321,84€

376,51€
Salva 54,67 € (14.52%)
1g
M163950-1g
—
2 Disponibile

511,01€

596,92€
Salva 85,91 € (14.39%)
Enter a quantity for the sizes you want to add.

Panoramica

Nanocs dithio NHS functionalized polyethylene glycol (PEG-S-S-NHS) is a reducing reagent cleavable and amine (-NH2) reactive PEG derivative that can be used to modify protein, peptide or any other material surfaces with their available amino groups. Dithiol-NHS esters react with primary amine groups at pH 7~8.5 to form stable amide bonds, meanwhile, disulfide bond can be cleaved by DTT, TCEP and other disulfide bond reducing reagents.

Specifiche

Specifiche e purezza
MW 1000 Da
Condizioni di conservazione di stoccaggio
Protected from light,Store at -20°C,Argon charged
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDataOggetto
B2320063B2320063Certificate of AnalysisMar 18, 2026 M163950
B2320406B2320406Certificate of AnalysisMar 18, 2026 M163950
B2320455B2320455Certificate of AnalysisMar 18, 2026 M163950
Proprietà chimiche e fisiche
Solubilità10 mg/mL, clear in water, chloroform, DMSO.
SensibilitàMoisture sensitive;Light sensitive
Domande frequenti e articoli
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No vendor-validated application protocols are provided for this SKU. Not specified for this item; refer to CoA/Spec Sheet. The following generic, literature-based outlines may assist in planning (research use only):

Example A: NHS–amine conjugation to a protein (general)

  • Dissolve the reagent in dry DMSO (10–50 mM) under argon. Prepare protein in phosphate buffer (pH 7.8, 10–50 mM) with 0.5 mM EDTA.
  • Add reagent dropwise to protein (2–10 eq per estimated accessible lysine). Incubate 30–60 min at 4–25°C.
  • Quench unreacted NHS with ethanolamine or Tris only after desired coupling. Desalt (spin column) to remove succinimide and solvent.

Example B: Thiol–maleimide coupling (general)

  • Reduce thiols with TCEP freshly (molar ratio 1:1 to 5:1) and desalt to remove excess reductant if incompatible.
  • Combine with maleimide-functional partner in phosphate buffer at pH 7.0; incubate 15–60 min. Purify by SEC or dialysis.

Note: Volumes, concentrations, and exact stoichiometries should be optimized empirically for each substrate. Always perform small-scale pilots.

Biological Roles

This product is a synthetic multifunctional PEG reagent and does not possess intrinsic biological roles in metabolism or signaling. The following notes are general, literature-based context for PEG and reactive groups; they are not medical/clinical claims and not specific to this SKU.

  • PEG backbone: Commonly used to enhance hydrophilicity, reduce protein adsorption, and impart stealth characteristics to surfaces. PEG is generally considered biologically inert and resistant to many enzymes.
  • NHS ester: A chemical activation motif for creating amide bonds with primary amines on biomolecules (e.g., lysine side chains, N-termini). The NHS group itself is a leaving group and is not retained post-coupling.
  • Dithiol handle: Provides two thiol groups capable of forming reversible disulfide linkages or undergoing selective addition to maleimides and activated alkenes. In biological contexts, thiol-disulfide exchange can be redox-responsive.

Applications in biochemistry (research-only)

  • Site-averaged lysine modification of proteins or surfaces via NHS chemistry, followed by thiol-specific attachment of probes/ligands.
  • Construction of redox-cleavable linkages via disulfides, enabling environmental responsiveness in vitro.

Item-specific biological activity data — Not specified for this item; refer to CoA/Spec Sheet.

Buffer Applications

As a reactive crosslinking reagent rather than a buffering agent, this product is not used to establish or maintain pH. However, buffer choice is critical to its successful use. Guidance below is general and literature-based.

  • Avoid buffers containing primary or secondary amines (e.g., Tris, glycine, HEPES derivatives with free amines) during the NHS-amine coupling step, as they will compete and quench the NHS ester.
  • Suitable buffers for NHS coupling: Phosphate (PBS without amines), bicarbonate/carbonate, or MES adjusted to pH 7.2–8.3 depending on desired rate vs. hydrolysis.
  • Maintain low metal ion concentrations or include 0.2–1 mM EDTA to reduce thiol oxidation and metal-catalyzed side reactions.
  • For thiol–maleimide reactions, use phosphate or PBS at pH 6.5–7.5 to favor thiol selectivity and suppress competing amine additions.
  • Degas buffers (argon or nitrogen sparge) and, where appropriate, include a mild, amine-free reductant (e.g., TCEP) immediately prior to thiol conjugation to maintain dithiols in the reduced state.

Item-specific buffer formulations, pH ranges, or recipes — Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

Sustainability considerations (general for PEG reagents)

  • Pros: PEG-based linkers are water-compatible and can enable aqueous bioconjugations, reducing reliance on chlorinated or highly toxic solvents. Reactions at ambient temperature reduce energy input.
  • Cons: NHS ester synthesis and use often involve carbodiimides and polar aprotic solvents (DMF, DCM) with EHS concerns; thiol chemistry can require reducing agents and metal chelators.

Greener choices and practices (literature-informed, not item-specific)

  • Use water or aqueous buffers for the conjugation step whenever feasible; prepare concentrated stocks in dry DMSO/ACN and dilute into buffer immediately before addition to the target.
  • Favor 2-MeTHF or CPME instead of chlorinated solvents where organic handling is necessary (solubility permitting).
  • Replace DMF with acetonitrile or high-purity ethanol for short operations if compatible.
  • Choose enzymatic or carbodiimide-free activation strategies when only amide formation is needed (e.g., NHS-free active esters or enzyme-mediated ligations), noting tradeoffs in scope and rate.
  • Minimize excess reagent and quench efficiently to limit waste of NHS byproducts (succinimide is relatively benign but contributes to COD in aqueous effluents).

Tradeoff snapshot (general)

  • NHS esters: fast, selective amine coupling but moisture sensitive and often require polar aprotic solvents.
  • Alternative handles (e.g., epoxy, aldehyde): more stable but less selective or require harsher conditions.
Pharmaceutical Uses

This reagent is intended for research use only (per Product Data). The following describes general roles of related PEG reagents in formulation/manufacturing contexts; no clinical/therapeutic claims are made.

  • Surface/passivation of devices and particles: PEGylation can reduce protein fouling during in vitro processing and characterization of materials.
  • Conjugation process aid: NHS-bearing PEGs are used to derivatize amine-containing substrates (proteins, peptides, polymers) in process development. Dithiols allow orthogonal thiol attachment, including to maleimide-functional excipients or gold surfaces for assay components.
  • Hydrogel/network fabrication: Dithiol reactivity supports crosslinking strategies for in vitro model systems or prototype delivery matrices during preformulation studies.

Regulatory/compendial status

  • No pharmacopeial monograph or excipient designation is provided for this specific item — Not specified for this item; refer to CoA/Spec Sheet.

Process considerations

  • Control of residual succinimide and verification of free thiol content can be important during process development. Implement appropriate analytical controls (HPLC, LC–MS, Ellman’s assay) and residual solvent monitoring.
Physical Properties

Item-specific physical constants (BP, MP, density, refractive index, exact solubility, logP, pKa) — Not specified for this item; refer to CoA/Spec Sheet.

General/literature characteristics for PEG-based NHS/thiol reagents (for context; not item specifications)

  • Physical state: Typically amorphous solid or viscous semi-solid depending on PEG molecular weight and end groups.
  • Color/appearance: Often white to off-white; hygroscopic tendencies are common for PEG derivatives.
  • Solubility (typical): High in water and polar organics (DMSO, DMF, acetonitrile); variable in alcohols; poor in nonpolar hydrocarbons. Actual solubility of this item is Not specified.
  • Partitioning: PEGylated reagents exhibit very low logP and high hydrophilicity; exact values depend on chain length and end groups.
  • Thermal behavior: NHS esters can undergo hydrolysis/acyl transfer upon heating and in moisture; thiols can oxidize to disulfides on air exposure.

Practical notes (general)

  • Prepare solutions freshly in dry, oxygen-poor solvents (e.g., anhydrous DMSO or DMF) to minimize NHS hydrolysis and thiol oxidation.
  • If aqueous use is required, buffer at pH ~7.5–8.5 immediately before conjugation to balance NHS reactivity and hydrolytic stability; keep exposure time short.

All numeric values specific to this SKU are Not specified for this item; refer to CoA/Spec Sheet.

Quality and Grades

Item-specific grade/purity and appearance — Not specified for this item; refer to CoA/Spec Sheet.

Context and implications for this reagent class (general knowledge)

  • NHS-activated PEG reagents are typically supplied as high-purity solids to ensure efficient bioconjugation. Trace moisture dramatically affects NHS content and increases hydrolysis products; tight control of residual solvents, water, and free NHS is desirable (values Not specified for this item).
  • Thiol content/oxidation state: For dithiol reagents, percent free –SH and disulfide content are critical. Suppliers may provide titration data (e.g., Ellman’s assay) — Not specified for this item.
  • Low bioburden/low endotoxin may be relevant for certain biointerfaces; unless stated, assume general research grade only.
  • Stabilization/packaging: Often packaged under inert gas with desiccant and light-protective containers to preserve NHS activity and keep thiols reduced — consistent with this product’s “Argon charged” and “Protected from light.”

What this means for users

  • Verify the current lot CoA for purity, residual solvents, free NHS content, and free thiol assay prior to critical conjugations.
  • Plan to use freshly opened material and minimize room-temperature exposure. For quantitative work, perform an in-house Ellman’s (DTNB) assay to confirm available thiol equivalents if not provided.
Reaction and Applications

Applications (general for this multifunctional PEG)

  • Bioconjugation hub: Combines an NHS-activated site for rapid amine coupling with a dithiol handle for further thiol chemistry (e.g., conjugation to maleimide-functional surfaces, gold nanoparticles, or formation of disulfide bridges/spacers).
  • Surface modification: Create amine-coupled monolayers/films on polymer, silica, or proteinaceous substrates, leaving free thiols for orthogonal attachment (e.g., to maleimide dyes, enzymes, or metal surfaces).
  • Protein and nanoparticle dual functionalization: Attach the NHS end to lysine residues on proteins or amine-decorated nanoparticles, then use the thiols to capture payloads by maleimide or to assemble redox-cleavable disulfides.
  • Hydrogel and network formation: Dithiols enable step-growth gelation via Michael addition to diacrylates/vinyl sulfones, while the NHS group can anchor the network to amine-bearing matrices.

Practical tips

  • Keep solutions anhydrous/degassed; charge vials with argon or nitrogen. Include EDTA (0.5–1 mM) in aqueous work to limit metal-promoted oxidation.
  • For NHS–amine coupling, target pH 7.5–8.3; use carbonate/bicarbonate or phosphate buffers devoid of primary/secondary amines (avoid Tris and glycine).
  • For thiol reactions, adjust pH 6.5–7.5 for maleimide selectivity; for Michael addition to acrylates, pH 7.5–8.5. Consider adding mild reductant (e.g., TCEP) immediately prior to use to maintain dithiols in reduced form.

All use is for research only (per Product Data).

Reaction Conditions

Item-specific optimal conditions are Not specified for this item; refer to CoA/Spec Sheet. The following are general, literature-based ranges for NHS/thiol PEG reagents.

NHS–amine coupling (general)

  • Solvent: Aqueous buffer (PBS, phosphate, bicarbonate) or mixed aqueous/ACN, DMSO, or DMF.
  • pH: 7.5–8.3 (balance rate vs. hydrolysis). Avoid amine-containing buffers.
  • Temperature: 4–25°C (lower temperatures reduce hydrolysis for longer reactions).
  • Time: 15 min to 2 h typical for proteins/surfaces; monitor to avoid over-modification.
  • Stoichiometry: 1.1–10 eq relative to available amines, depending on substrate.

Thiol conjugations (general)

  • Maleimide coupling: pH 6.5–7.5; 4–25°C; minutes to 1 h; use degassed buffer with 0.5–1 mM EDTA. Excess 1.1–2 eq per thiol.
  • Michael addition to acrylates/vinyl sulfones: pH 7.5–9.0; catalytic base; 25°C; 1–4 h.
  • Disulfide formation: Mild oxidants (e.g., air/O2, DMSO traces) at pH 7–8; minutes to hours; control to avoid overoxidation.

Handling tips

  • Prepare fresh solutions in dry DMSO/DMF/ACN; use within the same day. Keep under inert gas and protected from light.
  • Include TCEP immediately before thiol reactions to maintain reduced dithiols; avoid DTT when NHS coupling is ongoing (thiol/amine interference).

Expected yields and kinetics are substrate-dependent and not specified for this SKU.

Safety and Handling

Item-specific GHS data

  • Signal word, H-statements, GHS classification, pictograms — Not specified for this item; refer to the SDS.

General safety considerations for PEG–NHS/thiol reagents (literature/good practice)

  • Hazards: NHS esters are reactive acylating agents that may cause irritation to skin/eyes/respiratory tract. Free thiols can be irritants and may form disulfides; some have strong odors. PEG backbone is generally of low acute hazard but may enhance dermal absorption of actives.
  • PPE: Laboratory coat, nitrile gloves (change frequently), splash goggles. Use in a fume hood to avoid exposure to dust/aerosols and thiol vapors.
  • Incompatibilities: Moisture and basic aqueous media hydrolyze NHS esters; air/oxygen promotes thiol oxidation to disulfides; oxidants and metals may catalyze oxidation. Avoid amine-containing buffers until ready to conjugate.
  • First aid (overview; defer to SDS): Rinse skin/eyes with water for at least 15 minutes if contacted; remove contaminated clothing. If inhaled, move to fresh air. Seek medical attention if symptoms persist.
  • Waste: Quench residual NHS ester by controlled hydrolysis in basic aqueous media, then dispose per institutional and local regulations. Segregate thiol-containing waste due to odor/oxidation.

Storage and shipping (item-specific)

  • Store at −20°C, protected from light, under argon (from Product Data). Ship on ice with ice packs (from Product Data). Always consult the SDS for authoritative guidance.
Solvent Selection

Item-specific solvent parameters — Not specified for this item; refer to CoA/Spec Sheet.

General guidance for PEG–NHS/thiol multifunctional reagents

  • Anhydrous polar aprotics (preferred for stock solutions): DMSO, DMF, or acetonitrile minimize premature NHS hydrolysis and maintain thiols reduced (with inert atmosphere). Filter through 0.2 µm if needed.
  • Aqueous buffers (for conjugation): Prepare immediately before use in degassed buffers at pH 7.2–8.5 depending on target (amine coupling via NHS is efficient around pH 7.5–8.3; higher pH accelerates hydrolysis). Include chelators (e.g., 0.2–1 mM EDTA) to suppress metal-catalyzed thiol oxidation.
  • Alcohols: Short-chain alcohols can be miscible but may accelerate NHS hydrolysis; use cautiously.
  • Nonpolar solvents: Generally poor for PEG dissolution.

When to choose alternatives

  • For exclusively thiol–maleimide coupling without amine reactivity, consider PEG dithiols without NHS. For amine-only activation, mPEG–NHS without thiols may simplify handling.

Small comparison (general)

  • DMSO: excellent solubilizer; low volatility; hygroscopic (dry before use).
  • DMF: excellent solubilizer; may contain amine impurities — use high-purity, low-amine grades.
  • ACN: good for short-term handling; lower boiling point eases removal; may limit very high MW PEG solubility.
Storage and Reconstitution

Item-specific storage conditions (from Product Data)

  • Store at −20°C.
  • Protected from light.
  • Argon charged (store under inert atmosphere; minimize oxygen exposure).
  • Shipped in ice chest with ice pads.

General reconstitution guidance (literature-based; not item specifications)

  • Open vial only after equilibrating to room temperature in a dry environment to prevent condensation ingress.
  • Dissolve immediately before use in dry, oxygen-free solvent (e.g., anhydrous DMSO, DMF, or ACN). For aqueous work, dilute from a concentrated anhydrous stock into degassed buffer.
  • Target working concentrations: commonly 1–50 mM for stock solutions depending on application; exact values Not specified for this item.
  • If aliquoting, distribute under inert gas into dry, amber vials. Refreeze promptly at −20°C or below. Avoid repeated freeze–thaw; use single-use aliquots.
  • Stability considerations: NHS esters hydrolyze with moisture/heat; dithiols oxidize to disulfides upon air exposure. Verify integrity by analytical methods (HPLC, Ellman’s assay) before critical experiments.

Any item-specific shelf life, purity on opening, or stabilizers — Not specified for this item; refer to CoA/Spec Sheet.

Structure and Identity

Item-specific identifiers provided: CAS, CID, InChIKey, SMILES, Molecular Formula, and exact Molecular Weight — Not specified for this item; refer to CoA/Spec Sheet.

Overview

  • The name “Methoxy PEG dithiol NHS” denotes a multifunctional polyethylene glycol (PEG) reagent featuring:
    • A terminal methoxy capping group (mPEG) on one end of the PEG chain (nonreactive, increases hydrophilicity and reduces non-specific interactions).
    • A dithiol functionality (two free thiol groups) providing nucleophilicity for thiol–maleimide coupling, Michael additions to acrylates/vinyl sulfones, or disulfide exchange/formation.
    • An N-hydroxysuccinimide (NHS) active ester functionality enabling rapid, selective acylation of primary amines (e.g., lysine residues, amino surfaces) under mildly basic conditions.

Structural features (general description; literature-based)

  • Backbone: Flexible, hydrophilic –(CH2–CH2–O)–n– PEG chain.
  • End groups: One terminus methoxy-capped (–O–CH3). Additional termini incorporate a dithiol motif (–SH/–SH) and an NHS-activated carboxylate/carbonate moiety (succinimidyl ring).
  • Functional group set: Ether repeats (PEG), thiols (–SH), activated ester (NHS), possible ester/carbonate linker between PEG and NHS.
  • Stereochemistry: None expected on the PEG backbone; NHS ring is achiral; thiol-bearing fragments typically achiral.

2D verbal depiction

  • A linear PEG chain with one end capped by –OCH3, and the opposite end bearing a multifunctional linker where an NHS succinimide ring is attached via an ester/carbonate, with a pendant spacer terminating in two thiols (–SH, –SH). Exact topology and PEG length are item-specific and Not specified for this item; refer to CoA/Spec Sheet.
Synthetic Utility

Functional group leverage (general)

  • NHS ester: Efficient amide bond formation with primary amines under mild conditions. Useful for late-stage installation of PEG spacers onto amine-bearing small molecules, polymers, or biomolecules.
  • Dithiol: Two thiols enable bifunctional attachment or crosslinking through:
    • Thiol–maleimide coupling (rapid, selective at pH ~6.5–7.5).
    • Michael addition to acrylates/vinyl sulfones (base-catalyzed, pH ~7.5–9).
    • Disulfide formation/exchange for redox-responsive linkages.
  • PEG spacer: Increases water compatibility, reduces aggregation, and imparts flexibility; can improve solubility of hydrophobic conjugation partners.

Retrosynthetic planning

  • Use the NHS end to anchor the PEG to the amine-bearing core first, preserving the dithiol for a second, orthogonal modification step.
  • Where premature thiol oxidation is a concern, hold the thiols in situ reduced (TCEP) or use protecting groups with subsequent deprotection after NHS coupling (item-specific protection state Not specified).

Analytics and control

  • Verify coupling by MS (mass shift equals PEG + linker minus NHS), NMR (disappearance of succinimide resonances after hydrolysis/coupling), and Ellman’s assay for thiol equivalents.
  • Monitor hydrolysis by tracking succinimide release (HPLC/UV at ~260 nm; general guidance).
Target Specificity

This product is a chemical reagent, not a biological affinity reagent. No antigen, epitope, species reactivity, clone, or isotype applies.

Item-specific target specificity data — Not applicable/Not specified for this item.

Domande frequenti

How should this product be stored?
Store at ?20 °C, protected from light, under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.